Haleon sees strong first quarter
20th Apr 2023 07:00
(Sharecast News) - Haleon posted first-quarter sales ahead of expectations on Thursday, boosted by a strong cold and flu season.
Read moreHaleon declares maiden dividend amid profit growth
2nd Mar 2023 08:03
(Sharecast News) - Consumer health business Haleon proposed its maiden dividend on Thursday as the GSK spinoff said price hikes and efficiencies had led to profit growth and increased cash flow.
Read moreThursday preview: Euro area CPI, Haleon in the spotlight
1st Mar 2023 09:30
(Sharecast News) - The market spotlight on Thursday will shift towards the euro area where consumer price data are due out that may help inform opinions of the near-term path for interest rates in the bloc.
Read moreRecord vaccine sales boost profits at GSK
1st Feb 2023 07:18
(Sharecast News) - Fourth-quarter profits at GSK came in ahead of expectations on Wednesday, boosted by strong demand for the drug giant's blockbuster shingles vaccine.
Read moreBarclays upgrades Haleon to 'overweight'
7th Dec 2022 12:34
(Sharecast News) - Barclays upgraded Haleon on Wednesday to 'overweight' from 'equalweight' after a US Court threw out lawsuits alleging that GSK's former heartburn drug, Zantac, had caused cancer.
Read moreFormer GSK unit Haleon posts 16% rise in Q3 sales
10th Nov 2022 07:22
(Sharecast News) - Haleon, the former consumer health arm of GSK, on Thursday reported a 16.1% increase in third-quarter revenue, driven by higher prices, and forecast organic sales growth of 8-8.5%.
Read moreThursday preview: US CPI, Haleon in focus
9th Nov 2022 16:17
(Sharecast News) - All eyes on Thursday would be on the US consumer price report for October.
Read moreUS green lights GSK vaccine for use during pregnancy
10th Oct 2022 07:58
(Sharecast News) - GSK's whooping cough vaccine has been approved for use in pregnant women in the US.
Read moreHaleon reported operating profits grow 22% in H1
20th Sep 2022 07:03
(Sharecast News) - Consumer healthcare company Haleon saw operating profits grow more than 20% in the six months ended 30 June, driven by increased profits and margins.
Read moreRBC Capital starts Haleon at 'sector perform'
16th Aug 2022 10:40
(Sharecast News) - RBC Capital Markets initiated coverage of GlaxoSmithKline's consumer health spinoff Haleon on Tuesday at 'sector perform' with a 300p price target.
Read moreGSK to 'vigorously defend' Zantac claims; Haleon says not a party to claims
12th Aug 2022 07:26
(Sharecast News) - GlaxoSmithKline said on Friday that it would "vigorously defend" all claims related to its discontinued heartburn drug Zantac.
Read moreGSK, Haleon, Sanofi slump amid Zantac litigation woes
11th Aug 2022 12:35
(Sharecast News) - Shares in GlaxoSmithKline, Haleon and Sanofi tumbled on Thursday amid concerns about legal proceedings related to Glaxo's former blockbuster heartburn drug Zantac.
Read moreDirector dealings: Haleon non-execs spend over £0.5m between them
3rd Aug 2022 15:42
(Sharecast News) - Consumer products giant Haleon found itself on the list of director deals on Wednesday, after two of its non-executive directors bought more than half a million pounds worth of shares between them.
Read moreHaleon H1 revenues climb
27th Jul 2022 07:08
(Sharecast News) - Healthcare group Haleon said on Wednesday that revenues had climbed in the six months ended 30 June, principally driven by organic revenue growth, higher prices, and an improved volume mix.
Read moreCredit Suisse starts Haleon at 'outperform'
19th Jul 2022 13:06
(Sharecast News) - Credit Suisse has initiated coverage of Haleon, GlaxoSmithKline's recently spun out consumer healthcare arm, at 'outperform' with a 368p price target.
Read more